Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3488984rdf:typepubmed:Citationlld:pubmed
pubmed-article:3488984lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3488984lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:3488984lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:3488984lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:3488984lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3488984pubmed:issue1lld:pubmed
pubmed-article:3488984pubmed:dateCreated1986-10-22lld:pubmed
pubmed-article:3488984pubmed:abstractTextNew class I antigens in linkage disequilibrium with HLA-A antigen are demonstrated in PHA T and EBV preferential target cells using human alloantisera. These new antigens are defined as class I antigens by immunoprecipitation of a 41-12 k dimer. The molecule is shown to be distinct from the HLA-A, -B, -C molecule and in particular from the A3 molecule as in sequential immunoprecipitations, the depletion of the HLA-A, -B, -C molecule or A3 molecule (44-12 k) has no effect on the new molecule (41-12 k). Being present on the PHA T cells and lymphoblast lines, these antigens are considered as new epitopes involved in the the cell activation process.lld:pubmed
pubmed-article:3488984pubmed:languageenglld:pubmed
pubmed-article:3488984pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3488984pubmed:citationSubsetIMlld:pubmed
pubmed-article:3488984pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3488984pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3488984pubmed:statusMEDLINElld:pubmed
pubmed-article:3488984pubmed:monthSeplld:pubmed
pubmed-article:3488984pubmed:issn0198-8859lld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:GenetetBBlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:FauchetRRlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:CharronD JDJlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:MerdrignacGGlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:TurmelPPlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:BouhallierOOlld:pubmed
pubmed-article:3488984pubmed:authorpubmed-author:BoscherMMlld:pubmed
pubmed-article:3488984pubmed:issnTypePrintlld:pubmed
pubmed-article:3488984pubmed:volume17lld:pubmed
pubmed-article:3488984pubmed:ownerNLMlld:pubmed
pubmed-article:3488984pubmed:authorsCompleteYlld:pubmed
pubmed-article:3488984pubmed:pagination3-20lld:pubmed
pubmed-article:3488984pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:meshHeadingpubmed-meshheading:3488984-...lld:pubmed
pubmed-article:3488984pubmed:year1986lld:pubmed
pubmed-article:3488984pubmed:articleTitleNew class I in man: serological and molecular characterization.lld:pubmed
pubmed-article:3488984pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3488984lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3488984lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3488984lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3488984lld:pubmed